Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • plabaj
    Member
    • Oct 2010
    • 95

    #1

    CAMDA2020 @ ISMB, 13-14.07 Montreal, Canada

    Dear Colleagues,


    The Call for Contributions to CAMDA is now open!

    CAMDA is a full conference track at ISMB (www.camda.info).

    Researchers world-wide take the CAMDA Challenge (contest.camda.info) - compete with the best in an open-ended data analysis contest!

    Your choice of challenges 2020:
    * The Hi-Res Cancer Data Integration Challenge presents clinical and matched molecular profiles, with read level data for individual genomes. Explore non-standard genomes and splicing events for better prognosis.
    * The CMap Drug Safety Challenge presents clinical toxicity results, cellular and molecular responses to hundreds of drugs. Compare and integrate a range of cell line assays to predict the severity of the drug induced liver injury in humans.
    * The Metagenomic Geolocation Challenge presents thousands of city microbiome profiles in the context of climate data. Construct multi-source microbiome fingerprints and predict the ecological niche or exact geographical origin of mystery samples.

    Join us for a stimulating scientific meeting and lively discussions in Montreal 13-14 July 2020!

    Follow us on twitter @CAMDA_conf


    See you in Montreal!

    For the organizing committee,
    Joaquin Dopazo, Seville, Spain
    Diane Kovats, U.S.A.
    David Kreil, Vienna, Austria
    Paweł Łabaj, Kraków, Poland
    Weida Tong, Little Rock, U.S.A.
    Wenzhong Xiao, Stanford/Boston, U.S.A.


    Background:

    CAMDA was founded in 2000 (Nature 411, 885. Nature 424, 610) to provide a forum for the critical assessment of different techniques used in large-scale data analysis in the life-sciences, including but not limited to high-dimensional gene expression profiling. It aims to establish the state-of-the-art in analysis methods for Big Data in the Life Sciences, as well as identify progress and highlight promising directions for future efforts. To this end, CAMDA adopted the approach of a community-wide contest, with the scientific community analysing the same data sets. Researchers worldwide are invited to take the CAMDA challenge, which has become a prominent fixture (cf. Nature Methods 5, 569).

    Selected contributions are presented though talks and posters. Results and methods of the different analyses are discussed and compared at the conference, with delegates voting for the best presentations. Extended papers are published in a special issue of Biology Direct (fully indexed and open access). Methods papers are eligible for the regular ISMB proceedings track in Bioinformatics.

    Keynotes by leading researchers in the field provide further focus points for discussion at the meeting, and have recently included talks by Atul Butte and Sandrine Dudoit (Stanford), Mark Gerstein (Yale), Curtis Huttenhower (Harvard), John Quackenbush (Dana Farber Cancer Institute, Boston), Chris Sander (Memorial Sloan Kettering Cancer Center, New York), Eran Segal (Weizmann Institute, Israel), John Storey and Olga Troyanskaya (Princeton), and Terry Speed (Berkeley & WEHI).
    Pawel Labaj

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...